Adaptive refractory period within implantable cardioverter-defib

Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

607 13, 607 4, A61N 139

Patent

active

054703425

ABSTRACT:
An implantable cardioverter-defibrillator (ICD) adaptively adjusts the refractory period and sensitivity setting of its sensing channel in order to optimally detect depolarization signals indicative of intrinsic cardiac rhythm or tachycardias, or depolarization signals indicative of fibrillation. In one embodiment, the ICD utilizes first and second depolarization signal processing channels, each having first and second refractory periods and first and second sensitivity settings, respectively. The sensitivity settings of the first processing channel are adaptively adjusted to sense normal depolarization signals and tachycardias. The sensitivity settings of the second processing channel are adaptively adjusted to sense fibrillation. Both the first and second refractory periods begin following either a paced depolarization or a sensed depolarization.

REFERENCES:
patent: 4708142 (1987-11-01), DeCote
patent: 4708144 (1987-11-01), Hamilton et al.
patent: 4712555 (1987-12-01), Thornander et al.
patent: 4774952 (1988-10-01), Smits
patent: 4809697 (1989-03-01), Causey et al.
patent: 4817605 (1989-04-01), Sholder
patent: 4944299 (1990-07-01), Silvian
patent: 4989602 (1991-02-01), Sholder et al.
patent: 4998975 (1991-03-01), Cohen et al.
patent: 5040534 (1991-08-01), Mann et al.
patent: 5103820 (1992-04-01), Markowitz
patent: 5103822 (1992-04-01), Duncan
patent: 5330504 (1994-07-01), Somerville et al.
patent: 5395393 (1995-03-01), Wickham
Luceri, et al., PACE, vol. 14, pp. 1870-1874 (Nov. 1991).
Cannom, PACE, vol. 15, pp. 1-5 (Jan. 1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Adaptive refractory period within implantable cardioverter-defib does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adaptive refractory period within implantable cardioverter-defib, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adaptive refractory period within implantable cardioverter-defib will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2010131

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.